ARTICLE | Clinical News
Anthrasil anthrax immune globulin IV regulatory update
March 30, 2015 7:00 AM UTC
FDA approved a BLA from Emergent for Anthrasil anthrax immune globulin IV (AIGIV) to treat inhalational anthrax in combination with antibacterial drugs. The approval triggered a $7 million payment to...